GeneSoft Licenses Rights to Factive from LG Life Sciences

By Business Review Editor

Pharma Deals Review: Vol 2002 Issue 30 (Table of Contents)

Published: 2 Nov-2002

DOI: 10.3833/pdr.v2002.i30.977     ISSN: 1756-7874

Section: Licensing



GeneSoft and LG Life Sciences entered into a licensing agreement for LG’s quinolone antibiotic, Factive® (Gemifloxacin mesylate) for the treatment of bacterial infections...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details